Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
General Use-Results Survey of COMLEX OTIC SOLUTION 1.5%
jRCT2031240141Recruiting
- Sponsor
- CEOLIA Pharma
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levofloxacin in external otitis, chronic otitis media (COM) and acute otitis media (AOM), sponsored by CEOLIA Pharma. Primary endpoints: Safety under routine medical care and Effectiveness under routine medical care. Started Jun 2024; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
external otitischronic otitis media (COM)acute otitis media (AOM)
Beyond the preview
Go deeper on jRCT2031240141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240141.